Professor Knut Reinert is a leading figure in algorithmic bioinformatics at the Free University of Berlin, where he holds a professorship in the Department of Mathematics and Computer Science. He also maintains a significant affiliation with the Max Planck Institute for Molecular Genetics in Berlin, where he leads the Efficient Algorithms for Omics Data group. His research spans both institutions through the Reinert Lab, which focuses on developing novel computational approaches for biological data analysis. Reinert's educational background includes a Diploma in Computer Science (1994) and a Doctorate (Dr. Ing./Ph.D., 1999, with honors) from the Max-Planck-Institut for Computer Science and Universität des Saarlandes in Saarbrücken. Prior to his professorship, he worked as a computer scientist under Prof. Gene Myers at Celera Genomics in Rockville, USA (1999-2002). His primary research interests center on algorithmic bioinformatics with specific focus on developing novel algorithms and data structures for biomedical mass data analysis. This includes creating mathematical models for genomic sequence analysis and algorithms for mass spectrometry data to detect differential protein expression between normal and diseased samples. His work bridges the gap between computational tool development and practical biological applications, with particular emphasis on NGS and proteomics data. The publications and projects led by Prof. Reinert demonstrate a consistent focus on advancing computational methods in bioinformatics. His research spans genomic sequence analysis, RNA research (particularly long non-coding RNAs), parallel computing applications, and GPU acceleration for biological data processing. The work shows increasing sophistication in handling large-scale biological datasets through innovative algorithmic approaches. Intel® Parallel Computing Center designation for his lab CUDA Research Center status DFG funding of 530 thousand Euros for RNA research de.NBI funding of 2 million Euros BMBF funded projects 'LIVE-DREAM' and 'EssBar' Prof. Reinert leads multiple significant research projects and has established strong collaborations with international partners including Texas A&M, Kings College London, Eberhardt-Karls Universität Tübingen, Robert-Koch-Institute, and various Turkish institutions. His lab receives funding from major organizations including DFG, BMBF, and Intel. The Reinert Lab maintains active teaching responsibilities at FU Berlin, offering courses at BSc, MSc, and PhD levels using both traditional and innovative learning concepts like e-learning and inverted classrooms. The Reinert Lab consists of two interconnected research groups that work closely with experimental biologists and medical researchers to develop practical computational solutions for real-world biological problems. The lab has established itself as a key player in the German and international bioinformatics community through its development of the widely-used SeqAn library and participation in national infrastructure initiatives.
جستجوی استاد راهنمای دانشگاهی
برای مسیر پژوهشیتان، استاد راهنما، استاد دانشگاه و پژوهشگر مناسب را پیدا کنید و با آنها ارتباط بگیرید.
نمایش ۱-۱۵ از ۴۷۶ استاد راهنما
اطلاعات پروفایلها از صفحات عمومی دانشگاهها گرفته شده و ممکن است بهروز نباشد.
Harri Lähdesmäki is an Associate Professor (tenured) at the Department of Computer Science, Aalto University, where he leads the Computational Systems Biology research group. His work focuses on probabilistic machine learning and deep generative models with applications in biomedicine and molecular biology. Key Research Interests: Probabilistic machine learning, deep generative models, computational biology, bioinformatics, longitudinal data modeling Contact: harri.lahdesmaki@aalto.fi | Konemiehentie 2, 02150 Espoo, Finland His recent publications highlight advancements in: Gaussian process priors for scalable deep generative models Single-cell analysis of immune repertoires in leukemia and diabetes Probabilistic deconvolution methods for RNA-seq data Epigenetic analysis using hidden Markov and mixed models Transformer-based survival prediction and missing data handling Harri’s work integrates mechanistic modeling with Bayesian inference, particularly applied to immunology, cancer biology, and early disease prediction.
Dieter Braun is a Professor in the Faculty of Physics at Ludwig Maximilian University of Munich (LMU), leading the Functional NanoSystems research group. He serves as speaker of the CRC 235 Emergence of Life and coordinates the Molecular Origins component of the Origins Cluster. Dr. Braun holds an ERC Synergy Grant (starting April 2025), leads the CRC 392 Molecular Evolution (starting April 2024), and is a Fellow in the Max Planck School Matter to Life (since October 2023). His research focuses on understanding the physical mechanisms that could have led to the emergence of Darwinian evolution from prebiotic molecules on early Earth. Braun's laboratory investigates non-equilibrium settings, particularly asymmetrically heated open cracks in rocks, which create intricate wet-dry cycles, temperature gradients, and fluidic effects that could drive molecular evolution. His work bridges physics, chemistry, and biology to explore how dead molecules might combine through physical forces into autonomous mechanisms of evolution. Analysis of Braun's recent publications reveals a strong focus on thermal gradients and non-equilibrium physics in prebiotic environments. His research demonstrates how heat flows can concentrate molecules, drive polymerization, create pH gradients, and enable non-enzymatic replication of nucleic acids. The publications span high-impact journals including Nature, Nature Physics, and Nature Chemistry, showing interdisciplinary work connecting physics, chemistry, geology, and biology in the context of life's origins. Klung-Wilhelmy Weberbank Price (2011) Technology Transfer Price of the DPG (with LMU and NanoTemper) Deutscher Innovationspreis (2012) Step Award (2012) Dr. Braun has successfully mentored numerous PhD students, including Stefan Duhr and Philipp Baaske who founded the award-winning startup NanoTemper Technologies. His research is supported by multiple prestigious grants including ERC Starting, Advanced, and Synergy Grants, as well as funding from the Simons Collaboration on the Origins of Life. His laboratory collaborates extensively with other researchers across disciplines and institutions, particularly with Hannes Mutschler in the new ERC Synergy project. The Braun laboratory operates within the CRC 235 Emergence of Life and the Origins Cluster at LMU Munich, with strong connections to the Max Planck Society through the Max Planck School Matter to Life. The research group maintains active collaborations with geochemists, biophysicists, and molecular biologists to create comprehensive experimental models of prebiotic environments.
Professor Marek Sanak serves as Full Professor at the Department of Internal Medicine, Jagiellonian University Medical College in Cracow, Poland. He concurrently holds leadership positions as Acting Director of the Department of Forensic Medicine, Head of the Division of Molecular Biology and Clinical Genetics, and Vice-Rector for Research and International Cooperation since 2016. His academic foundation includes: MD from Jagiellonian University Medical College Specialization in Pediatrics and Genetics PhD from Jagiellonian University Research appointments at Harvard University, University of Paris VI, and University of Zurich Professor Sanak's research integrates clinical genetics with molecular immunology, focusing on asthma pathogenesis, lipid mediators of inflammation, and genetic diagnostics. His laboratory employs advanced techniques including deep DNA/RNA sequencing to identify biomarkers and elucidate disease mechanisms. The work bridges fundamental molecular discoveries with clinical applications in respiratory diseases, allergic disorders, and forensic medicine, demonstrating particular expertise in aspirin-exacerbated respiratory disease and epigenetic regulation of inflammatory pathways. Analysis of his recent publications reveals a strategic evolution from classical asthma research toward molecular genetics and viral pathogenesis. His 2017-2021 work increasingly incorporates epigenetic approaches (DNA methylation, microRNA profiling) while expanding into SARS-CoV-2 research during the pandemic. The publications demonstrate interdisciplinary integration across immunology, respiratory medicine, and molecular diagnostics, with consistent focus on translational applications. His distinguished career has been recognized through numerous honors: The Lancet Investigators Award on Asthma (1997) Polish Ministry of Health Individual Prize (1999) Jagiellonian Laurel (2012) Pro Arte Docendi Award (2014/15) Gold Medal for Long Service (2019) Top 2% of world scientists ranking (Elsevier 2022) As Vice-Rector for Research, Professor Sanak has significantly expanded international collaborations with King's College London, University of Southampton, and University of Zurich. His leadership has secured substantial funding for molecular diagnostics and inflammatory disease research while mentoring numerous early-career researchers. He delivers invited lectures globally for organizations including the American Thoracic Society and European Academy of Allergy and Clinical Immunology. Professor Sanak directs integrated research units across the Division of Molecular Biology and Clinical Genetics, Division of Biochemical and Molecular Diagnostics at University Hospital Cracow, and the Department of Forensic Medicine. These teams combine clinical service with basic research to advance genetic diagnostics and understand disease mechanisms, maintaining forensic genetics expertise developed over 20 years of practice.
- Genetics
- Asthma
- Lipid mediators of inflammation
- +۷ مورد دیگر
Dana Pe'er is a Professor and Chair of the Computational and Systems Biology Program at the Sloan Kettering Institute (SKI) of Memorial Sloan Kettering Cancer Center. She is also an Investigator of the Howard Hughes Medical Institute and holds the Alan and Sandra Gerry Endowed Chair. Dr. Pe'er leads an interdisciplinary research group that combines advanced genomics approaches with machine learning to address fundamental questions in biomedical science, with particular focus on cancer biology, developmental biology, and immunology. Dr. Pe'er earned her PhD from Hebrew University in Jerusalem, Israel. Her academic journey includes a postdoctoral fellowship with George Church at Harvard Medical School. Before joining Memorial Sloan Kettering Cancer Center in 2016, she held faculty positions at Columbia University. Dr. Pe'er's research focuses on understanding cellular plasticity, the consequences of intra-tumor heterogeneity, cancer evolution and metastasis, and the mechanisms by which regulatory circuits go awry in disease. Her lab combines single-cell and spatial profiling technologies with machine learning approaches to investigate gene regulation, cellular plasticity, and cell-cell communication in the contexts of cancer, immunity, and development. They are particularly interested in how organisms develop from a single cell to generate diverse cell types, how epigenetic control rewires during development, and how cells communicate to execute multicellular responses. Analysis of Dr. Pe'er's recent publications reveals a strong focus on developing computational methods for single-cell and spatial genomics data analysis. Her work spans cancer types including pancreatic, prostate, colorectal, and breast cancer, with emphasis on tumor heterogeneity, metastasis mechanisms, and cellular plasticity. A significant portion of her research involves creating novel algorithms and tools like CellRank, REUNION, and SEACells that enable researchers to extract meaningful biological insights from complex genomic datasets. 2023 Class of 2023 Inductee - American Academy of Cancer Research (AACR) Academy 2023 Innovator Award - International Society for Computational Biology (ISCB) 2021 Fellow - International Society for Computational Biology (ISCB) Howard Hughes Medical Institute Investigator (2021) 2019 Ernst W. Bertner Memorial Award - University of Texas MD Anderson Cancer Center 2016 Lenfest Distinguished Faculty Award - Columbia University 2014 Director's Pioneer Award - National Institutes of Health 2014 Overton Prize - International Society for Computational Biology (ISCB) Dr. Pe'er is known for her dedicated mentorship approach, describing herself as "a mama bear" who cares deeply about her trainees while expecting independence, innovation, and hard work. She mentors numerous PhD students and postdocs in her lab. Her HHMI Investigator award provides approximately $9 million over seven years, enabling ambitious research directions. She also collaborates extensively with the Single-cell Analytics and Innovation Lab (SAIL) at MSK to generate new data from emerging technologies, working closely with wet-lab collaborators at MSK and beyond to apply computational methods to cutting-edge datasets across multiple disease areas. The Pe'er Lab is an interdisciplinary group of computational biologists with diverse backgrounds ranging from pure mathematics to clinical medicine. They work closely with wet-lab collaborators to apply their computational methods to cutting-edge datasets across cancer, immunology, and developmental biology. The lab is described as open, supportive, collaborative, and fun, with access to world-class facilities at the Sloan Kettering Institute. Dr. Pe'er's work continues to push the boundaries of computational biology and cancer research, with the ultimate goal of developing more effective, personalized therapies for cancer patients.
Ki-Woong Park is a tenure-track full Professor in the Department of Computer and Information Security at Sejong University. He leads the System Security and Computer Engineering Research (SysCore) Lab, which focuses on system security research with numerous ongoing projects funded by major Korean research institutions including IITP, NRF, and KRIT. Sejong University, Department of Computer and Information Security System Security and Computer Engineering Research (SysCore) Lab Leader Member of IEEE, IEEE Computer Society, and ACM Education: Ph.D. in Electrical Engineering & Computer Science, KAIST (Advisor: Prof. Kyu-Ho Park) M.S. in Electrical Engineering & Computer Science, KAIST (Advisor: Prof. Kyu-Ho Park) B.S. in Computer Science, Yonsei University (Summa Cum Laude) Exchange Student at University of California, Los Angeles (UCLA) Professor Park's research focuses on designing, building, and analyzing secure systems, particularly for cloud computing, networked systems, and embedded systems. His work often involves reevaluating existing security mechanisms and actual system implementations with subsequent evaluation in real computing environments. He has made significant contributions to areas including cloud security, IoT security, ransomware detection, moving target defense, and metaverse security. His research approach emphasizes both theoretical foundations and practical implementation, with numerous publications in top-tier security and systems venues. His recent publications (2023-2024) demonstrate a strong focus on emerging security challenges in modern computing environments, particularly in metaverse platforms, UAV systems, and edge computing. These works span both theoretical security frameworks and practical implementations, with an emphasis on visualization techniques, hardware-based security mechanisms, and AI-enhanced security analysis. His research shows a clear progression from traditional cloud and network security toward next-generation security challenges in immersive virtual environments and cyber-physical systems. Scientific Awards: Microsoft Research Fellowship (2009-2010) Best Poster Gold Award at WISA 2020 Best Paper Award at MobiSec'18 Professor Park actively mentors numerous graduate and undergraduate students through the SysCore Lab, with current members including Ph.D. students, MS students, and undergraduate researchers. His research is supported by multiple significant grants, including the NRF Outstanding Researcher-Mid-career Researcher project, IITP Information Security Core Source Technology Development, and Defense Technology Advancement Research Institute projects. These grants total tens of billions of Korean won and address critical national security challenges in cyber defense, cloud security, and metaverse technologies. The SysCore Lab, under Professor Park's leadership, maintains a strong industry and government collaboration network, with part-time researchers from organizations including Hyundai Duty Free, Astron Security, Korea University, and various military cyber commands. This unique structure enables the lab to address both theoretical security challenges and practical implementation issues in real-world systems.
Igor Jurisica is a Professor at the University of Toronto and a Senior Scientist at the Krembil Research Institute’s Data Science Discovery Centre for Chronic Diseases. He also serves as Visiting Scientist at IBM CAS, Scientific Director of the World Community Grid, and Chief Scientist at the Creative Destruction Lab (Rotman School of Management). His research focuses on integrative computational biology, data mining, and AI-driven models for cancer mechanisms, drug discovery, and chronic disease management. Key affiliations include the Osteoarthritis Research Program, Schroeder Arthritis Institute, and leadership roles in open science initiatives like the World Community Grid, a global distributed computing platform with 810,000+ volunteers. Jurisica’s work bridges computational tools (e.g., NAViGaTOR visualization platform, MirDIP databases) and clinical applications, emphasizing explainable AI in healthcare. Research interests span proteomics, microRNA regulation, systems vaccinology, and multi-omics integration for disease stratification. Notable contributions include identifying prognostic signatures in cancer and osteoarthritis, machine learning models for drug repurposing, and sportomics analyses of athletic biomarkers. He has been recognized as a Thomson Reuters Highly Cited Researcher (2014-2016) and ranked among the Top 100 AI Leaders in Oncology (2023). His labs develop open-access tools like PathDIP, OsteoDIP, and miRAnno to advance translational research.
Prof. Dr. Christian Mayer is a Professor in Physical Chemistry at the Faculty of Chemistry, University of Duisburg-Essen. He serves as Head of the working group focusing on origin of life research, nanocapsules, and NMR spectroscopy techniques. His research group is located at Universitätsstraße 5, D-45141 Essen, Germany, with contact information including phone number +49 201 183-2570. Prof. Mayer's research interests primarily focus on the origin of life in deep tectonic fault zones of the first continental fragments, where he collaborates with Prof. Dr. Ulrich Schreiber from the Faculty of Biology and Prof. Dr. Oliver Schmitz from Applied Analytical Chemistry. His work investigates how vesicle formation occurs in tectonic fault systems through cyclic phase transitions of carbon dioxide, creating ideal conditions for molecular evolution. He specializes in pulsed field gradient NMR (PFG-NMR), high-resolution NMR, and solid-state NMR techniques to characterize nanoscale systems including nanocapsules, vesicles, and microemulsions. His recent publication trends reveal a strong interdisciplinary focus spanning physical chemistry, prebiotic chemistry, and astrobiology. The articles demonstrate increasing integration of computational methods with experimental approaches, particularly in analyzing molecular structures and dynamics. His research has evolved from fundamental studies of nanocapsule systems to broader investigations of protocell formation mechanisms under early Earth conditions, with recent work extending to astrobiological contexts including potential life formation on Titan. Prof. Mayer has established significant collaborations across multiple disciplines, particularly with geologists and biologists, to investigate the physical chemical processes that could have led to the emergence of life. His work bridges fundamental physical chemistry with practical applications in nanomedicine, particularly in developing artificial oxygen carriers based on nanocapsule technology. His laboratory utilizes high-pressure facilities to simulate early Earth crust conditions, with a particular focus on supercritical CO 2 environments. The working group combines experimental approaches with theoretical modeling to understand vesicle formation processes and their implications for the origin of cellular life.
- Origin of life
- Nanocapsules
- NMR spectroscopy
- +۵ مورد دیگر
David B. Bensimon is a world-leading biophysicist and Professor in the Department of Chemistry and Biochemistry at the University of California, Los Angeles, holding the prestigious Regent's Professor title since 2007. He maintains a dual academic position, serving as Directeur de Recherche at the French National Center for Scientific Research (CNRS) at the Ecole Normale Supérieure (ENS) in Paris while teaching and conducting research at UCLA for one quarter each year. His academic journey began with a Ph.D. from the University of Chicago in 1986 under Leo Kadanoff, followed by postdoctoral research at Bell Laboratories and ENS Paris. Professor Bensimon's research spans multiple frontiers in biophysics and molecular biology, with particular expertise in single-molecule studies of nucleic acids and their proteins. His laboratory pioneered the Magnetic Trap technique for manipulating individual DNA molecules, enabling groundbreaking investigations into DNA mechanics, topoisomerase interactions, and molecular combing. His recent work has expanded into optogenetics, developmental biology using zebrafish models, and cancer research, with significant contributions to understanding how single-cell oncogene activation leads to tumorigenesis. His research output shows remarkable breadth across disciplines, with recent publications spanning biophysics, developmental biology, cancer research, and genomic technology development. Bensimon's work on opto-chemical tools has particularly transformed how researchers can control biological processes with unprecedented spatiotemporal precision, especially in zebrafish models. His laboratory has developed photoactivatable versions of key molecular tools including Cas9 (OptoCas9) and cyclofen systems that allow precise control of protein activity at the single-cell level. 2007 Regent's Professor at UCLA 1997 Vinci of Excellence Award for phospholipid vesicle research 1994 Jacques Monod Prize for Molecular Combing discovery Special Prize of the French Physical Society for DNA mechanics work ICAM Fellow KITP-UCSB Representative Bensimon has made significant contributions to both basic science and translational applications, co-founding Depixus for nucleic acid sequencing and epigenetic analysis. His laboratory continues to push boundaries in single-molecule biophysics while expanding into developmental biology and cancer research, with recent work demonstrating that activation of kRas in dedifferentiated cells increases tumorigenesis probability by two orders of magnitude. His mentorship has produced notable researchers including X. Michalet, and his theoretical work extends to the philosophical unification of scientific disciplines as evidenced by his book "The Unity of Science".
- Biophysics
- Single-Molecule Studies
- DNA Mechanics
- +۷ مورد دیگر
Rosana Collepardoمشاهده پروفایل
پژوهشگر ارشد
Dr. Rosana Collepardo is a Winton Advanced Research Fellow at the Cavendish Laboratory, University of Cambridge, where she leads a research group within the Theory of Condensed Matter (TCM) Group and is also affiliated with the Biological and Soft Systems group. Her research focuses on developing multi-scale computational models to investigate chromatin nanostructure, epigenetic regulation, and biomolecular condensates, with applications in understanding genome organization and sustainable data storage. Her primary research interests include: Computational biophysics of chromatin and epigenetics Mechanisms of biomolecular condensates and phase separation Nanoscale structure of the genome and DNA accessibility Multi-scale modeling from atomistic to mesoscale Design principles for chromatin-inspired data storage Analysis of her recent publications (2023-2025) reveals a dominant focus on chromatin organization, epigenetic mechanisms, and biomolecular condensates. Key trends include the role of nucleosome spacing, linker histones, and epigenetic modifications in chromatin phase separation, alongside investigations into condensate aging, material properties, and the physical principles of phase transitions in RNA-protein systems. Her work consistently integrates computational modeling with experimental validation. Notable scientific awards include: Winton Advanced Research Fellowship ERC Starting Grant Dr. Collepardo actively mentors PhD and MPhil students, including Sivapalan Chelvaniththilan (MPhil in Physics, recipient of Gates and Winton Scholarships), Miguel Garcia Ortegon (MPhil in Scientific Computing), Stephen Farr (PhD in Computational Methods for Materials Science), Akshay Sridhar (MPhil in Scientific Computing), and Adiran Garaizar (PhD with EPSRC scholarship). Her group secures competitive funding through ERC grants and student scholarships. The Collepardo group, established in 2016 at the Maxwell Centre, Cavendish Laboratory, comprises postdoctoral researchers, PhD students, and MPhil candidates. They collaborate with experimental groups to study chromatin dynamics and biomolecular condensates using advanced computational techniques, contributing to fundamental biological understanding and potential biotechnological applications.
Dr. Shelley Wickham is an Associate Professor and ARC DECRA Fellow at the University of Sydney, holding joint appointments in the Schools of Chemistry and Physics. She serves as a Westpac Research Fellow and leads the DNA Nanotechnology Group at the Sydney Nano Institute. Dr. Wickham is also co-Champion of the Sydney Nano Institute Grand Challenge project in Molecular Nanorobotics for Health, co-lead of the School of Physics Grand Challenge on Nanoscale brain navigation for targeted drug delivery, and faculty mentor of the University of Sydney BIOMOD team. Bachelor of Science and Master of Science in Physics from University of Sydney PhD in Condensed Matter Physics from University of Oxford Postdoctoral Fellow at Harvard Medical School, Dana-Farber Cancer Institute, and Wyss Institute Dr. Wickham's research focuses on self-assembling nanotechnology and molecular robotics, particularly in the design and assembly of programmable nanostructures out of DNA. Her work spans applications in cell biology, materials science, and nanomedicine. Current research projects include design and synthesis of self-assembling DNA nanostructures, proto-cells made of DNA gels that move under flow, new plasma fabrication methods for biomolecule micropatterning, and DNA computation circuits for navigating the brain using machine learning. Her research aligns with the Faculty of Science Research Strengths in Molecules to Materials, Preventing and Treating Disease & Disorder, and Next Generation Materials. Analysis of Dr. Wickham's recent publications reveals a consistent focus on DNA nanotechnology with increasing sophistication in structural complexity and biological applications. Her work has evolved from fundamental DNA origami structures to increasingly complex multi-component systems with practical applications in nanomedicine and biomimetic engineering. Recent publications show strong interdisciplinary collaboration across chemistry, physics, biology, and engineering disciplines, with emphasis on real-world applications including drug delivery systems and biomolecular sensors. ARC DECRA Fellow Westpac Research Fellow BIOMOD World Champions (2019) Dr. Wickham actively mentors PhD students and postdoctoral researchers in her DNA nanotechnology group. She has secured significant research funding including ARC Discovery Projects, Westpac Scholarships, and NSW Health grants. Her current grants support projects such as '3D Bio-Nanomaterial Displays with Designer Architectures and Functions' and 'RNA aptamer sensing devices for rapid detection of blood clotting.' Dr. Wickham encourages applications from diverse backgrounds and maintains active collaborations with researchers at Harvard, Oxford, and other international institutions. Dr. Wickham leads the DNA Nanotechnology Group at the University of Sydney, which is part of the Sydney Nano Institute. Her lab focuses on building tools from DNA origami - including tweezers, spanners, wrenches and springs - to better understand biological processes at the nanoscale. The group has achieved notable success with the BIOMOD team winning world championships in 2019, and continues to develop innovative approaches to molecular robotics for healthcare applications.
Yuri Y. Gleba is a renowned academic scientist affiliated with the Institute of Cell Biology and Genetic Engineering at the Ukrainian Academy of Sciences in Kiev, Ukraine. As Founder and Director (1989–2010) and current Honorary Director, he has shaped plant biotechnology research through pioneering work in transient expression systems and molecular farming. Key Roles: Founder and Director of Institute of Cell Biology and Genetic Engineering (1989–2010), Honorary Director (2010–present) Research Interests Plant genetics , plant physiology , and biotechnology underpin his work in genetic engineering , viral vector systems , and transgenic plant applications . His innovations include the Magnifection platform for rapid plant-based vaccine production and methods for RNA silencing enhancement in molecular farming. Scientific Recognition includes membership in six international academies (World Academy of Arts and Science, Academia Europaea, Leopoldina, Ukrainian Academy of Sciences, Lithuanian Academy of Science, Bavarian Academy of Sciences) and prestigious awards like the Koerber Prize , A. von Humboldt Prize , and state prizes from the USSR and Ukraine. His work has appeared in top journals including Proceedings of the National Academy of Sciences USA and FEBS Letters . Publications : Gleba's 15 most recent articles (2004–2010) focus on plant biotechnology applications, viral vector engineering, and molecular farming. Key trends include plant-based pharmaceutical production , transient expression systems , and transgene containment strategies . Laboratory and Collaborations : Founded and led the Institute of Cell Biology and Genetic Engineering, fostering international collaborations in plant biotechnology and genetic engineering research.
- Plant genetics
- Plant physiology
- Plant cell biology
- +۳ مورد دیگر
Tommy Lundbergمشاهده پروفایل
مدرس ارشد
Tommy Lundberg is a Senior Lecturer and Docent in Physiology at Karolinska Institutet. He works at the Department of Laboratory Medicine, Division of Clinical Physiology. His email address is tommy.lundberg@ki.se, and his postal address is H5 Laboratoriomedicin, H5 Klinisk Fysiologi Gustafsson, 141 52 Huddinge. Lundberg is affiliated with the university library and has held positions since 2022. Research Interests: Lundberg's research focuses on skeletal muscle mass and function adaptation, particularly in athletic performance, disease contexts, aging, and transgender individuals undergoing hormone therapy. He investigates molecular, metabolic, morphological, and functional responses to resistance and aerobic exercises. His work also explores biological maturity selection biases in youth sports, bio-banding applications in soccer and ice hockey, and the impact of anti-inflammatory drugs on muscle hypertrophy. Article Trends: Lundberg's recent publications (2025–2024) cover topics like sex differences in disc golf, muscle atrophy in space exposome, longitudinal hormone therapy effects in transgender individuals, and bio-banding in youth sports. Earlier works delve into molecular pathways in muscle hypertrophy, concurrent training effects, mitochondrial function, and imaging techniques (CT/MRI) for muscle assessment. Scientific Recognition: Most prominent young researcher in Sport Science, Swedish Central Association for Sport Promotion (SCIF), 2017 Teaching and Editorial Roles: Lundberg teaches human physiology and sports science in nursing, physiotherapy, and biomedical analytics programs. He leads a contract education course in advanced exercise physiology and contributes to a PhD course on scientific writing. He is an Associate Editor for Frontiers in Physiology - Exercise Physiology (2022) and a member of the editorial board for Translational Exercise Biomedicine (2024). Collaborations and Expertise: He collaborates with the Swedish Football Association and Swedish Ice Hockey Association on bio-banding studies. Lundberg served as an invited speaker at the ACSM Annual Meeting (2024) on transgender athletes and as an expert panelist for World Rugby's transgender workshop (2020). His supervision includes Andrea Tryfonos (2021) and thesis evaluations at Mid Sweden University and Linköping University.
- Physiology
- Sports Science
- Molecular Biology
- +۳ مورد دیگر
Professor Ghazaleh Tabatabai serves as Head of Department for Clinical and Experimental Neuro-Oncology at the Hertie Institute for Clinical Brain Research, University of Tübingen. She leads a multidisciplinary research group focused on translational neuro-oncology with active collaborations through the German Glioma Network, German Cancer Consortium (DKTK), European Organisation for Research and Treatment of Cancer (EORTC), European Association of Neuro-Oncology (EANO), and International Consortium on Meningioma (ICOM). Her research program centers on molecular mechanisms of tumorigenesis, therapy resistance, and treatment-induced vulnerabilities in nervous system tumors. The laboratory employs CRISPR screening technologies, molecular profiling, and preclinical models to identify therapeutic targets, with particular expertise in glioma and meningioma biology. Current projects span from discovery through validation to clinical application, including phase I/II trials of novel therapies such as CureVac's mRNA vaccine candidate CVGBM. Recent publications demonstrate leadership in molecular classification of meningiomas, CRISPR-based target discovery, immunotherapy development, and clinical trial design. Her work on the TRACE app for patient-reported outcomes and the PRIDE trial for dose-escalated radiation therapy represents significant clinical translation efforts. The 2024-2025 publication record shows strong productivity with high-impact papers in Neuro-Oncology, Nature Medicine, and Genome Biology. Elected spokesperson of the DFG Board for Neuroscience (2024) Active participation in EANO guideline development Leadership in multiple international consortia including ICOM Principal investigator for clinical trials including N2M2/NOA-20 umbrella trial Professor Tabatabai mentors a large research team including PhD students, medical doctoral candidates, and postdoctoral researchers. Her laboratory maintains active clinical collaborations across neurosurgery, radiation oncology, and medical oncology departments. She is featured in the 'Key To My Research' podcast discussing tumor intelligence and regularly presents at major neuro-oncology conferences including ASCO, EANO, and SNO.
- Neuro-Oncology
- Glioma Biology
- Meningioma Research
- +۵ مورد دیگر
Professor Michael Thompson is a tenured faculty member in the Department of Materials Science and Engineering at Cornell University's College of Engineering. He holds the Dwight C. Baum Professorship in Engineering and specializes in advanced materials processing, particularly semiconductor materials under pulsed laser exposure. His research focuses on transient thermal processing (nanosecond to sub-second timescales) for material property modification and characterization, with applications in semiconductors, EUV lithography, and photonic materials. Thompson has authored over 120 papers and 20 patents, emphasizing industrial challenges like front-end junction formation and flexible electronics. Education: B.S. in Physics (CalTech, 1979), M.S./Ph.D. in Physics (Cornell, 1982/1984). He has received prestigious awards including the North American Award for Technical Contribution to the Semiconductor Industry (2009), multiple Cornell Excellence in Teaching Awards, and the Stephen H. Weiss Presidential Fellow designation (2021). His teaching focuses on thermodynamics and electronic properties, with a commitment to making abstract concepts accessible through real-world examples. Service: Leads curriculum development, ABET accreditation, and industry outreach. His lab develops novel methods for autonomous materials discovery using AI-driven approaches. Current projects include laser spike annealing for semiconductor doping and high-throughput synthesis of metastable materials.